The Influence of Glycemic Control on the Prognosis of Japanese Patients Undergoing Percutaneous Transluminal Angioplasty for Critical Limb Ischemia

OBJECTIVE To reveal the influence of preoperative factors on the prognosis of patients undergoing percutaneous transluminal angioplasty (PTA) for critical limb ischemia (CLI). RESEACH DESIGN AND METHODS We recruited 278 Japanese patients who underwent PTA for CLI between 2003 and 2009. The outcome measures were mortality and major amputation. Cox proportional hazards regression analyses were performed. RESULTS The prevalence of diabetes was 71%, and A1C was 7.0 ± 1.4%. The follow-up period was 90 ± 72 weeks, and 48 patients underwent major amputations and 89 died. The presence of diabetes in the whole population and A1C level in the diabetic population had no influence on morality; rather, mortality was associated with age (P = 0.007), impaired activities of daily living (P < 0.001), hemodialysis (P < 0.001), and albumin level (P = 0.010). In contrast, the presence of diabetes and A1C level had significant association with major amputation (P = 0.012 and P = 0.007, respectively). The quartile analysis showed that diabetic subjects with an A1C ≥6.8%, but not <6.8%, had a significantly higher risk of major amputation than nondiabetic subjects. The adjusted hazard ratio of diabetes with A1C ≥6.8% was 2.907 (95% CI 1.606–5.264) (P < 0.001). CONCLUSIONS Diabetes with poor glycemic control is associated with major amputation, but not mortality, in CLI patients undergoing PTA. Prognostic indicators seem somewhat different between survival and limb salvage in the population.

[1]  J. Hamming,et al.  Functional status as a prognostic factor for primary revascularization for critical limb ischemia. , 2010, Journal of vascular surgery.

[2]  G. Falk,et al.  Serum albumin and total lymphocyte count as predictors of outcome in hip fractures. , 2010, Clinical nutrition.

[3]  Julie W. Anderson,et al.  The Relationship between Hemoglobin A1c Values and Healing Time for Lower Extremity Ulcers in Individuals with Diabetes , 2009, Advances in skin & wound care.

[4]  M. Peppa,et al.  Advanced glycoxidation products and impaired diabetic wound healing , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  A. Morabito,et al.  Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia , 2009, Diabetes Care.

[6]  K. Woo,et al.  The biology of chronic foot ulcers in persons with diabetes , 2008, Diabetes/metabolism research and reviews.

[7]  I. Baumgartner,et al.  Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. , 2007, Journal of vascular surgery.

[8]  B. Nordestgaard,et al.  Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome , 2007, Diabetologia.

[9]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[10]  A. Gottsäter,et al.  Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. , 2005, Journal of vascular surgery.

[11]  D. Fry,et al.  Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects , 2005, Critical care medicine.

[12]  M. Lepäntalo,et al.  Diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. , 2004, Journal of vascular surgery.

[13]  J. Hux,et al.  Quantifying the risk of infectious diseases for people with diabetes. , 2003, Diabetes care.

[14]  T. Magee,et al.  A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia. , 2003, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[15]  P. De Cata,et al.  Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: clinical results of a multicentric study of 221 consecutive diabetic subjects , 2002, Journal of internal medicine.

[16]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[17]  P. Desgranges,et al.  The Management and Outcome of Critical Limb Ischaemia in Diabetic Patients: Results of a National Survey , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[18]  Demetre Labadarios,et al.  Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. , 2010, Nutrition.

[19]  F. Fowkes,et al.  Bypass surgery for chronic lower limb ischaemia. , 2008, The Cochrane database of systematic reviews.

[20]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[21]  R. Rutherford,et al.  Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of Vascular Surgery.

[22]  A. Whittemore Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.